HDAC9 and cancer: Ever since the discovery of the cytotoxic/cancerostatic drug 5‐Azacytidin, a potent inhibitor of DNA methylation, and vorinostat, a potent pan‐HDAC inhibitor, research on potential epigenetic drugs for various cancers has made significant progress.